This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As the technology exhausts its honeymoon period, and companies in all industries find new ways of using it to get ahead of the competition, a new race is on. According to IFI Claims , an organization that tracks patent data, one way of finding out where competition is heating up is to look at what kinds of patents people are applying for.
A survey from global talent marketplace Andela found that 88% of enterprise companies are looking for top tech talent in other countries. These countries offer competitive salaries, a lower cost of living compared to other major tech hubs, and better opportunities for quality of life and work-life balance.
While the stage has been set for growth, analysts predict that growth will be accompanied by intense competition among dominant carriers. It will be up to each telco’s competitive intelligence professional to deliver the insights needed to capture market share. These are some of the U.S.
“The global pharmaceuticals market size is expected to gain momentum by reaching USD 2,151.1 The role also has competitive intelligence functions. The new hire will have to develop a CI process in support of the company’s pipeline planning processes and manage all ongoing activities for monitoring competitive developments.
Despite ongoing regulatory scrutiny over its labor practices and supply chain transparency, Shein continues to dominate the global fast-fashion industry. With demand for lithium-ion batteries surging, CATLs secondary listing in Hong Kong is expected to raise $5 billion to fuel its global expansion and strategic partnerships.
Specifically, within the pharma and biotech sectors, there have been 22 deals announced so far in 2023 — again, a low number compared to the 70 made over the same period last year. Additionally, unprofitable biopharma, aka most biotech companies, is expected to invest $1.1
After three volatile years, rife with challenging macroeconomic conditions — from a global pandemic and wars to far-reaching supply chain issues — the M&A space has its fair share of ups and downs. Many pharma companies with expiring patents are on the hunt to acquire biotech companies to address gaps in drug pipelines.
In this role, Brad will advise our teams and clients from the Health and Life Sciences industries, and promote our portfolio of solutions, including market and business research, competitive intelligence, thought leadership, data analytics, strategic insights, and shared services. www.fuld.com.
Market Analysis : A valuable tool for conducting market research , as it can analyze large volumes of market data, predict market trends, analyze customer preferences, and provide a snapshot of the competitive landscape. Forecasting Analysis : Analyze financial data to generate potential forecasts.
On the other hand, 2022 and 2023 brought mass layoffs , falling market capitalizations, and a weakening of global tech spending. 2023 was all about learning the use cases of genAI, as companies raced to introduce their own genAI offerings and capabilities into a fiercely competitive market (i.e. OpenAI’s ChatGPT ). billion by 2032.
According to PwC’s Annual Global CEO survey, 54% of healthcare industry CEOs intend to make at least one acquisition in the next three years. According to an outlook published by PwC , “large-cap pharma companies are expected to continue pursuing mid-sized biotech companies to fill pipeline gaps in the face of impending patent cliffs.
Pricing: Learn how the price of Stream by AlphaSense ’s premium expert transcript library can keep you ahead of the competition. Stream by AlphaSense’s hand-picked team of compliance reviewers have collectively reviewed over 26,000 transcripts in the past tw o years to provide our clients with confidence about the safety of their research.
He has a wealth of cross-industry experience in accelerating companies’ growth and raising capital, having spent more than fifteen years in SaaS companies as CFO and COO in industries as varied as manufacturing and biotech. He received his Bachelor of Arts in Economics and Political Science from Williams College. Adi received his B.S.
Global Healthcare Market – 2021. However, the emergence of a Delta variant of COVID-19 in Europe, the US, and China is fueling the need for ‘booster shots’ to sustain global recovery. According to the IMF, the global economy is likely to grow by 5.9% Global Healthcare M&A: Unprecedented Fightback 2.0.
Over the last three years, the COVID-19 pandemic brought new energy to manufacturing vaccines for a myriad of global diseases and health conditions. Moderna, BioTech, and Melanoma It started with what scientists considered to be impossible this past December. a potential cure for skin cancer. a potential cure for skin cancer.
In their paper on Deep Tech: The Great Wave of Innovation , BCG and Hello Tomorrow explain “what deep tech is, how it works, how different stakeholders can contribute to it, and how it can be harnessed for competitive advantage.” The global tech industry is projected to hit $5T in 2021 , which would represent a 4.2% With 6,415.
We believe that this focus on accessibility and sustainability represents an alternative and attractive opportunity in supporting innovative solutions for global healthcare challenges. This renewed interest in rare disease therapeutics can be attributed to the U.S. Want to dig even deeper into the top takeaways from J.P.
Our analysis of global data gathered from multiple trial registries provided a compelling snapshot of the recent IO clinical landscape and prompted several unanswered questions regarding future evolution and the impact on manufacturers competing in the space. Obtain details on competitor clinical trial locations.
Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers a competitive advantage. Sarah has 18 years of experience in global transformation initiatives, strategic business planning, merger and acquisition, and change management.
In 2024, global M&A volume reached $3.4 North America led global M&A activity with 50% of deal volume, followed by EMEA at 25% and APAC at 22%. The tech sector accounted for 19% of global deal volume, followed by healthcare at 10% and finance at 9%. trillion seen in 2021. Novo Holdings Acquisition of Catalent: $16.5
Boston’s innovation business ecosystem—from biotech startups in Kendall Square to fintech firms downtown—relies heavily on quality consumer insights. B2B International B2B International is a global market research firm specializing in B2B market research across various industries. Get your insights 2. Year Founded: 1998 3.
So that’s the seeing through the windshield, like I spend so much time looking at yesterday’s numbers and last week’s numbers and today’s competitive numbers, am I really looking next week and two months from now and six months from now and three years from now, right? John Dick: Right. [00:36:04].
From biotech startups in Torrey Pines to craft breweries in North Park, San Diego businesses rely on solid consumer insights to guide their decisions. The city has some well-establised traditional local agencies and modern research companies, each with their own expertise. Wherever you are, and whenever you need it.
billion), restructuring expense at ~$800 million (was $600 million) and global tax rate at ~23% (was 24%), while short-term incentive compensation expense is expected at ~$1.6 Customers have multiyear R&D product road maps, and the competitive environment for customers is more challenging today than it’s ever been.
Meanwhile, annual global investment in deep tech quadrupled from $15B to over $60B in 20162020 , signaling that investors see shorter paths to profit and indicating more technologies funded five or more years ago have now reached commercial readiness. It was hard to imagine this pace 5-10 years ago.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content